
















system1.	 The	 standard	 therapy	 consists	 of	 maximal	 possible	 surgical	 resection	 with	
concomitant	radiation	(RT)	and	chemotherapy.	An	accurate	definition	of	the	tumor	volume	is	
of	utmost	importance	for	guiding	radiation	therapy.	Currently	the	target	volume	delineation	
is	 based	 on	 CT	 and	MRI2,3.	 In	 this	 project	 we	 investigated	 the	 feasibility	 of	 incorporating	





F98	GB	cells	 inoculated	 in	 the	 rat	brain	were	 imaged	using	T2-	and	contrast-enhanced	T1-
weighted	(CE-T1w)	MRI.	After	tumor	growth,	a	30	min	[18F]-FET	(30min	p.i.)	or	[18F]-FAZA	(2h	











[18F]-FET	 and	 [18F]-FAZA	 showed	 an	 increased	 tumor	 uptake.	 After	 co-registration	 of	 the	
planning	CT	with	the	CE-T1w-MRI	and	PET	images,	PET-guided	RT	was	performed.	Using	three	
non-coplanar	arcs,	the	dose	delivered	to	the	normal	surrounding	brain	tissue	was	minimized.	
The	 average,	minimum	and	maximum	dose,	 as	well	 as	 the	D90-,	 D50-	 and	D2-	 values	were	
calculated	 for	 nine	 rats	 with	 both	 RT	 plans.	 The	 dose	 volume	 histograms	 (DVH)	 are	
represented	 in	figure	1.	A	slight	shift	to	the	right	for	the	graph	could	be	noted	of	the	DVH	
based	on	the	RT	with	PET	based	subvolume	boosting.	The	evolution	of	the	normalized	tumor	
volumes	 is	 shown	 in	 figure	2.	Significant	differences	were	 found	between	the	 therapy	and	







a	 significant	 difference	 was	 found	 between	 therapy	 and	 no	 therapy,	 but	 no	 significant	
difference	could	be	observed	between	the	three	treatment	groups.	Additional	 information	
from	molecular	 imaging	 techniques	enables	 the	visualization	of	metabolically	highly	active	
regions.	As	GB	are	highly	heterogeneous	solid	tumors,	the	concept	of	biological	target	volume	
and	multidimensional	conformal	RT	seems	promising.	
	
	
Figure	1:	Indication	of	the	overlapping	volume	of	the	three	rotating	bundles	(green,	A).	Dose	volume	histogram	with	isocenter	
based	on	the	center	of	the	gadolinium	containing	contrast	uptake	on	the	T1-weighted	MRI	(B).	Dose	volume	histogram	with	
the	second	isocenter	based	on	the	hot	spot	showed	by	the	PET	scan	(C).		
	
	
Figure	2:	Graphical	representation	of	the	median	change	of	the	tumor	volume	by	day.		
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